secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viatris Inc (VTRS)
CIK:        0001792044
Form:       8-K
Filed at:   2022-12-29T23:59:59+00:00
Accession:  0001193125-22-314765
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viatris appoints Elisha Finney and Scott Smith to Board; Dimick and Read retire
-------------------------------------------------------------------------------

- Neil Dimick and Ian Read retired from Viatris board effective Dec 28, 2022; no disagreement with company.
- Elisha Finney (former Varian CFO) and Scott Smith (BioAtla President, ex-Celgene) appointed as Class I directors effective Dec 29, 2022.
- Finney serves on boards of Mettler-Toledo, NanoString, ICU Medical; Smith is Chairman of Triumvira, board member of Apexigen and Refuge.
- Robert Coury, Executive Chairman, thanked retiring directors and welcomed new appointees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792044/000119312522314765/0001193125-22-314765-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792044/000119312522314765/d426713d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-314765

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer